title: Comparison of topical timolol gel to oral acetazolamide in the prophylaxis of viscoelastic-induced ocular hypertension after penetrating keratoplasty.
abstract: OBJECTIVE
  Viscoelastic-induced ocular hypertension following penetrating keratoplasty (PK) may result in endothelial cell loss and optic nerve damage.
  
  
  METHODS
  In a prospective, randomized, masked trial, two doses of oral sustained-release acetazolamide were compared to a single dose of topical 0.5% timolol gel after 40 PKs.
  
  
  RESULTS
  The mean preoperative intraocular pressure (IOP) was 17.4 mm Hg for the oral acetazolamide group and 16.7 mm Hg for the timolol gel group. The mean IOP on the first postoperative day was 17.9 mm Hg with oral acetazolamide and 12.9 mm Hg with timolol gel. One patient developed significant adverse reactions with oral acetazolamide; there were no adverse reactions with timolol gel.
  
  
  CONCLUSIONS
  Prophylactic use of timolol gel for viscoelastic-induced ocular hypertension after PK appears to offer better IOP control than oral acetazolamide, with potentially fewer adverse systemic effects.
authors.affiliation: Department of Ophthalmology, State University of New York Health Science Center at Brooklyn 11203, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Kanellopoulos
authors.forename: H D
authors.initials: HD
authors.lastname: Perry
authors.forename: E D
authors.initials: ED
authors.lastname: Donnenfeld
mesh_terms: D000086:Acetazolamide / Q000008:administration & dosage*; D000284:Administration, Oral; D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005782:Gels; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects*; D007429:Intraocular Pressure / Q000187:drug effects; D015948:Keratoplasty, Penetrating; D008297:Male; D009798:Ocular Hypertension / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D011183:Postoperative Complications; D011446:Prospective Studies; D013999:Timolol / Q000008:administration & dosage*
chemical_list: D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D005782:Gels; D013999:Timolol; D006820:Hyaluronic Acid; D000086:Acetazolamide